130 related articles for article (PubMed ID: 18678925)
1. Preliminary molecular dynamic simulations of the estrogen receptor alpha ligand binding domain from antagonist to apo.
McGee TD; Edwards J; Roitberg AE
Int J Environ Res Public Health; 2008 Jun; 5(2):111-4. PubMed ID: 18678925
[TBL] [Abstract][Full Text] [Related]
2. Structural basis for the deactivation of the estrogen-related receptor gamma by diethylstilbestrol or 4-hydroxytamoxifen and determinants of selectivity.
Greschik H; Flaig R; Renaud JP; Moras D
J Biol Chem; 2004 Aug; 279(32):33639-46. PubMed ID: 15161930
[TBL] [Abstract][Full Text] [Related]
3. Determination and analysis of agonist and antagonist potential of naturally occurring flavonoids for estrogen receptor (ERα) by various parameters and molecular modelling approach.
Puranik NV; Srivastava P; Bhatt G; John Mary DJS; Limaye AM; Sivaraman J
Sci Rep; 2019 May; 9(1):7450. PubMed ID: 31092862
[TBL] [Abstract][Full Text] [Related]
4. Structural insights into Resveratrol's antagonist and partial agonist actions on estrogen receptor alpha.
Chakraborty S; Levenson AS; Biswas PK
BMC Struct Biol; 2013 Oct; 13():27. PubMed ID: 24160181
[TBL] [Abstract][Full Text] [Related]
5. Activation helix orientation of the estrogen receptor is mediated by receptor dimerization: evidence from molecular dynamics simulations.
Fratev F
Phys Chem Chem Phys; 2015 May; 17(20):13403-20. PubMed ID: 25927714
[TBL] [Abstract][Full Text] [Related]
6. Conformational dynamics of the estrogen receptor alpha: molecular dynamics simulations of the influence of binding site structure on protein dynamics.
Celik L; Lund JD; Schiøtt B
Biochemistry; 2007 Feb; 46(7):1743-58. PubMed ID: 17249692
[TBL] [Abstract][Full Text] [Related]
7. Simulation of the different biological activities of diethylstilbestrol (DES) on estrogen receptor alpha and estrogen-related receptor gamma.
Nam K; Marshall P; Wolf RM; Cornell W
Biopolymers; 2003 Jan; 68(1):130-8. PubMed ID: 12579585
[TBL] [Abstract][Full Text] [Related]
8. Simulations reveal increased fluctuations in estrogen receptor-alpha conformation upon antagonist binding.
Ng HL
J Mol Graph Model; 2016 Sep; 69():72-7. PubMed ID: 27580485
[TBL] [Abstract][Full Text] [Related]
9. The structural basis of estrogen receptor/coactivator recognition and the antagonism of this interaction by tamoxifen.
Shiau AK; Barstad D; Loria PM; Cheng L; Kushner PJ; Agard DA; Greene GL
Cell; 1998 Dec; 95(7):927-37. PubMed ID: 9875847
[TBL] [Abstract][Full Text] [Related]
10. Structural insights into selective agonist actions of tamoxifen on human estrogen receptor alpha.
Chakraborty S; Biswas PK
J Mol Model; 2014 Aug; 20(8):2338. PubMed ID: 25060147
[TBL] [Abstract][Full Text] [Related]
11. Structural insight into the antagonistic action of diarylheptanoid on human estrogen receptor alpha.
Geetha Rani Y; Lakshmi BS
J Biomol Struct Dyn; 2019 Mar; 37(5):1189-1203. PubMed ID: 29557271
[TBL] [Abstract][Full Text] [Related]
12. Exploration of endocrine-disrupting chemicals on estrogen receptor alpha by the agonist/antagonist differential-docking screening (AADS) method: 4-(1-adamantyl)phenol as a potent endocrine disruptor candidate.
Nose T; Tokunaga T; Shimohigashi Y
Toxicol Lett; 2009 Dec; 191(1):33-9. PubMed ID: 19666091
[TBL] [Abstract][Full Text] [Related]
13. Elucidation of Agonist and Antagonist Dynamic Binding Patterns in ER-α by Integration of Molecular Docking, Molecular Dynamics Simulations and Quantum Mechanical Calculations.
Sakkiah S; Selvaraj C; Guo W; Liu J; Ge W; Patterson TA; Hong H
Int J Mol Sci; 2021 Aug; 22(17):. PubMed ID: 34502280
[TBL] [Abstract][Full Text] [Related]
14. Estrogen receptor beta activates the human retinoic acid receptor alpha-1 promoter in response to tamoxifen and other estrogen receptor antagonists, but not in response to estrogen.
Zou A; Marschke KB; Arnold KE; Berger EM; Fitzgerald P; Mais DE; Allegretto EA
Mol Endocrinol; 1999 Mar; 13(3):418-30. PubMed ID: 10076999
[TBL] [Abstract][Full Text] [Related]
15. Role of estrogen receptor ligand and estrogen response element sequence on interaction with chicken ovalbumin upstream promoter transcription factor (COUP-TF).
Klinge CM
J Steroid Biochem Mol Biol; 1999 Nov; 71(1-2):1-19. PubMed ID: 10619353
[TBL] [Abstract][Full Text] [Related]
16. The F domain of estrogen receptor α is involved in species-specific, tamoxifen-mediated transactivation.
Arao Y; Korach KS
J Biol Chem; 2018 Jun; 293(22):8495-8507. PubMed ID: 29632071
[TBL] [Abstract][Full Text] [Related]
17. Mutation of Leu-536 in human estrogen receptor-alpha alters the coupling between ligand binding, transcription activation, and receptor conformation.
Zhao C; Koide A; Abrams J; Deighton-Collins S; Martinez A; Schwartz JA; Koide S; Skafar DF
J Biol Chem; 2003 Jul; 278(29):27278-86. PubMed ID: 12736255
[TBL] [Abstract][Full Text] [Related]
18. Elucidating Binding Sites and Affinities of ERα Agonists and Antagonists to Human Alpha-Fetoprotein by In Silico Modeling and Point Mutagenesis.
Moldogazieva NT; Ostroverkhova DS; Kuzmich NN; Kadochnikov VV; Terentiev AA; Porozov YB
Int J Mol Sci; 2020 Jan; 21(3):. PubMed ID: 32019136
[TBL] [Abstract][Full Text] [Related]
19. Conformational transitions of the estrogen receptor monomer. Effects of estrogens, antiestrogen, and temperature.
Hansen JC; Gorski J
J Biol Chem; 1986 Oct; 261(30):13990-6. PubMed ID: 3771517
[TBL] [Abstract][Full Text] [Related]
20. Breast cancer-derived M543V mutation in helix 12 of estrogen receptor alpha inverts response to estrogen and SERMs.
Nichols M; Cheng P; Liu Y; Kanterewicz B; Hershberger PA; McCarty KS
Breast Cancer Res Treat; 2010 Apr; 120(3):761-8. PubMed ID: 19526339
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]